Eldacimibe
Eldacimibe (WAY-ACA-147) is a selective ACAT2 inhibitor used in research to investigate atherosclerosis and hypercholesterolemia. Its application extends to preclinical studies of cardiovascular and metabolic diseases, where it has been evaluated in both in vitro assays and in vivo animal models to assess its effects on cholesterol esterification and plaque formation.
Product Specifications
CAS Number
141993-70-6
Product Name Alternative
WAY-ACA 147, WAY-ACA147, WAY-ACA-147, UNII-4PBL76O2G8, ANA147, ANA-147, ACAT-2, ACA 147, ACA147, ACA-147, Eldacimibe
Field of Research
Metabolism Research
Purity
97.82% (May vary between batches)
Solubility
DMSO:50 mg/mL (78.75 mM)
Smiles
C (N (CC1=CC=C (CC (C) (C) C) C=C1) CCCCCC) (NC2=CC (C (C) (C) C) =C (O) C (C (C) (C) C) =C2) =C3C (=O) OC (C) (C) OC3=O
Molecular Formula
C39H58N2O5
Molecular Weight
634.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ethanolamine kinase (ETNK1) Human Over-expression Lysate
